Oluwatosin Smith is an Ophthalmology physician affiliated with Glaucoma Associates of Texas. OpenAlex indexes 39 publications with 1,649 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10740 N Central Expy
Suite 300
Dallas, TX 752312161
Telephone
214-360-0000Registry record last updated 30 Mar 2017.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Glaukos CorporationProgram year20259 payments$186,330openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202543 payments$61,968openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year202522 payments$26,174openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.5%Prostaglandin Analog25.7%Latanoprost72%Lumigan22%Travoprost6%Tafluprost1%Part D<11 patientsCarbonic Anhydrase Inhibitor23.5%Dorzolamide-Timolol75%Dorzolamide Hcl11%Simbrinza8%Brinzolamide6%Acetazolamide1%Part D≥359 patients+ 8 more classes in this area
Cardiovascular
12%Beta blocker12%Timolol Maleate100%Part D<11 patientsNervous system
3.3%Cholinergic Receptor Agonist3.3%Pilocarpine Hcl100%Part D≥102 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery
American Journal of Ophthalmology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”